1AI 14.3% 0.8¢ algorae pharmaceuticals limited

Ann: NTCELL and Parkinsons trial update, page-30

  1. 16,918 Posts.
    lightbulb Created with Sketch. 2406
    Well 15m shares sold so far on the back of the results.
    Pessimists will take the view that another 6 months will be needed to confirm the results and sell out at a loss now.
    Optimists will say there is enough here to show that it works better than simply "halting progression" in many patients and buy in at a bargain price

    I suspect the company will continue on monitoring and working on the other projects For those who don't know the company is working on trying to isolate the peptides produced by NTcell and will likely try to ready pilot trials on hearing loss and perhaps eye disease (mentioned at the AGM I think).

    The information is there you go back and look, but its not firm and there is no time line and it will depend on budget.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $13.49M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $34 4.285K

Buyers (Bids)

No. Vol. Price($)
9 8215316 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1837858 8
View Market Depth
Last trade - 10.00am 04/09/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.